{
  "BB4827_syn_1": "Proc: EBUS-TBNA.\nStations: 2R, 4R, 4L, 7, 11R.\nROSE: 4R/7 Malignant. Others benign/reactive.\nPlan: Oncology.",
  "BB4827_syn_2": "PROCEDURE: Endobronchial Ultrasound Staging.\nINDICATION: Mediastinal lymphadenopathy.\nFINDINGS: A systematic mediastinal evaluation was performed. Stations 2R, 4R, 4L, 7, and 11R were visualized and sampled. Rapid on-site evaluation (ROSE) indicated metastatic carcinoma in stations 4R and 7. Stations 2R, 4L, and 11R demonstrated reactive lymphocytes. No complications occurred.",
  "BB4827_syn_3": "Billing Code: 31653 (EBUS sampling 3+ stations).\nStations Sampled:\n1. 2R\n2. 4R\n3. 4L\n4. 7\n5. 11R\nTotal: 5 stations. Meets criteria for 31653.",
  "BB4827_syn_4": "Procedure: EBUS\nPt: [REDACTED]\nSteps:\n1. Scope in.\n2. Sampled 2R, 4R, 4L, 7, 11R.\n3. ROSE positive in 4R and 7.\n4. Others benign.\n5. Stable.\nPlan: Staging.",
  "BB4827_syn_5": "ebus note for susan taylor... did the full staging... hit 5 stations 2r 4r 4l 7 and 11r... rose said cancer in 4r and 7... rest looked reactive... patient did fine conscious sedation used... send for molecular markers.",
  "BB4827_syn_6": "EBUS-TBNA systematic approach. Station 2R: 9mm, 3 passes, ROSE shows reactive lymphocytes. Station 4R: 14mm, 4 passes, ROSE positive for metastatic carcinoma. Station 4L: 10mm, 3 passes, ROSE benign. Station 7: 17mm, 4 passes, ROSE positive for metastatic carcinoma. Station 11R: 8mm, 3 passes, ROSE adequate, benign. Staging indication: Yes. Systematic sequence: Yes.",
  "BB4827_syn_7": "[Indication]\nMediastinal adenopathy, PET unavailable.\n[Anesthesia]\nModerate Sedation.\n[Description]\nEBUS-TBNA of 5 stations (2R, 4R, 4L, 7, 11R). Malignancy id[REDACTED] in 4R and 7.\n[Plan]\nOncology referral.",
  "BB4827_syn_8": "Susan underwent an EBUS procedure to investigate enlarged lymph nodes. Since she couldn't have a PET scan, we sampled five different areas in her chest to be thorough. The pathologist in the room found cancer cells in the right paratracheal and subcarinal nodes. The other nodes were benign. We sent the samples for further genetic testing.",
  "BB4827_syn_9": "Procedure: Ultrasonic mediastinal staging.\nAction: Sampled stations 2R, 4R, 4L, 7, and 11R via transbronchial needle aspiration.\nFindings: Cytologic evidence of malignancy in 4R and 7. Benign cellularity elsewhere.",
  "BB4827": "Patient: [REDACTED] | MRN [REDACTED] | Birth: [REDACTED]\n\nClinical scenario: Mediastinal adenopathy on CT, patient cannot undergo PET (renal failure, diabetes)\n\nModerate sedation with midazolam/fentanyl, Ramsay 3, BP q5min monitoring\n\nEBUS-TBNA systematic approach:\nNo PET data available for correlation\n\nStation 2R: 9mm, 3 passes, ROSE shows reactive lymphocytes\nStation 4R: 14mm, 4 passes, ROSE positive for metastatic carcinoma\nStation 4L: 10mm, 3 passes, ROSE benign\nStation 7: 17mm, 4 passes, ROSE positive for metastatic carcinoma\nStation 11R: 8mm, 3 passes, ROSE adequate, benign\n\nStaging indication: Yes\nSystematic sequence: Yes (N3→N2→N1)\nAll samples adequate: Yes\nMolecular testing: Sent from station 4R\n\nPhotodocumentation of all accessible stations completed.\n\nPET CORRELATION NOT AVAILABLE - relied on size and ultrasound characteristics for targeting\n\nNo complications."
}
